thiotepa has been researched along with Cardiac Tamponade in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Cardiac Tamponade: Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We treated 19 women with malignant cardiac tamponade due to advanced breast cancer with subxiphoid pericardiocentesis and local thiotepa instillation." | 7.70 | Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). ( Antoniadou, S; Balamoutsos, N; Bishiniotis, TS; Katseas, G; Litos, AG; Mouratidou, D, 2000) |
| "We treated 19 women with malignant cardiac tamponade due to advanced breast cancer with subxiphoid pericardiocentesis and local thiotepa instillation." | 3.70 | Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). ( Antoniadou, S; Balamoutsos, N; Bishiniotis, TS; Katseas, G; Litos, AG; Mouratidou, D, 2000) |
| "A 56-year-old female with breast cancer after left partial mastectomy and subaxillary lymph node dissection was treated with adjuvant chemoradiotherapy." | 1.33 | [A case of recurrent breast cancer complicated with pericardial effusions and cardiac tamponade]. ( Ishiguro, A; Mitobe, S; Munakata, M; Okada, R; Sakata, Y; Shitara, K; Tomioka, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GOLDMAN, BS | 1 |
| PEARSON, FG | 1 |
| Shitara, K | 1 |
| Munakata, M | 1 |
| Ishiguro, A | 1 |
| Okada, R | 1 |
| Tomioka, R | 1 |
| Mitobe, S | 1 |
| Sakata, Y | 1 |
| Bishiniotis, TS | 1 |
| Antoniadou, S | 1 |
| Katseas, G | 1 |
| Mouratidou, D | 1 |
| Litos, AG | 1 |
| Balamoutsos, N | 1 |
3 other studies available for thiotepa and Cardiac Tamponade
| Article | Year |
|---|---|
MALIGNANT PERICARDIAL EFFUSION. REVIEW OF HOSPITAL EXPERIENCE AND REPORT OF A CASE SUCCESSFULLY TREATED BY TALC POUDRAGE.
Topics: Breast Neoplasms; Cardiac Surgical Procedures; Cardiac Tamponade; Drug Therapy; Exudates and Transud | 1965 |
[A case of recurrent breast cancer complicated with pericardial effusions and cardiac tamponade].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 2006 |
Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa).
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Cardiac Tamponade; Echocardiograph | 2000 |